Chester W. Über Lipoidgranulomatose. Virchows Arch Pathol Anat Physiol Klin Med [Internet]. 1930;279(2):561–602. Available from: https://doi.org/10.1007/BF01942684

Jaffe HL. Lipid (Cholesterol) granulomatosis. Metabolic, degenerative, and inflammatory disease of bones and joints. 1972;535–41.

Haroche J, Cohen-Aubart F, Amoura Z. Erdheim-Chester disease [Internet]. 2020. Available from: http://ashpublications.org/blood/article-pdf/135/16/1311/1724169/bloodbld2019002766c.pdf. Accessed 6 Sept 2023

The WHO Classification of Tumours Editorial Board 2020 WHO Classification of Tumours Soft Tissue and Bone Tumours 3 5 IARC Press Lyon 337 499

Papo M, Emile JF, Maciel TT, Bay P, Baber A, Hermine O, et al. Erdheim-Chester disease: a concise review, vol. 21. Current Rheumatology Reports: Springer; 2019.

Google Scholar 

Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood [Internet]. 2020 May 28;135(22):1929–45. Available from: https://doi.org/10.1182/blood.2019003507

Starkebaum G, Hendrie P. Erdheim–Chester disease. Vol. 34, Best Practice and Research: Clinical Rheumatology. Bailliere Tindall Ltd; 2020.

Kanakis M, Petrou P, Lourida G, Georgalas I. Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective. Vol. 67, Survey of Ophthalmology. Elsevier Inc.; 2022. p. 388–410.

Yelfimov DA, Lightner DJ, Tollefson MK. Urologic manifestations of Erdheim-Chester disease. Urology. 2014;84(1):218–21.

Article  PubMed  Google Scholar 

Estrada-Veras JI, O’Brien KJ, Boyd LC, Dave RH, Durham BH, Xi L, et al. The clinical spectrum of Erdheim-Chester disease: an observational cohort study. Blood Adv. 2017;1(6):357–66.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arnaud L, Gorochov G, Charlotte F, Lvovschi V, Parizot C, Larsen M, et al. Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients. Blood [Internet]. 2011 Mar 10;117(10):2783–90. Available from: https://doi.org/10.1182/blood-2010-10-313510

Croce L, Coperchini F, Magri F, Chiovato L, Rotondi M. The multifaceted anti-cancer effects of BRAF-inhibitors the wild type BRAF gene. Oncotarget [Internet]. 2019 [cited 2023 Aug 29];10(61):6623–40. Available from: www.oncotarget.com

Haroche J, Charlotte F, Arnaud L, Von Deimling A, Hélias-Rodzewicz Z, Hervier B, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120(13):2700–3.

Article  PubMed  CAS  Google Scholar 

Emile JF, Diamond EL, Hélias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Hyman DM, et al. Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease. Blood [Internet]. 2014;124(19):3016–9. Available from: https://www.sciencedirect.com/science/article/pii/S0006497120354161. Accessed 6 Sept 2023

Sun Z, Shen C. Differential diagnosis of rare diseases involving bilateral lower extremities with similar 99mTc-MDP bone scan patterns: analysis of a case series. Diagnostics (Basel). 2022 Apr 6;12(4).

Resnick D, Greenway G, Genant H, Brower A, Haghighi P, Emmett M. Erdheim-Chester disease. Radiology. 1982;142(2):289–95.

Article  PubMed  CAS  Google Scholar 

Arnaud L, Malek Z, Archambaud F, Kas A, Toledano D, Drier A, et al. 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum. 2009;60(10):3128–38.

Article  PubMed  Google Scholar 

Lenz O, Sancassani R, Bottino C, Fornoni A. Reversible bone pain and symmetric bone scan uptake in a dialysis patient treated with cinacalcet: a case report. J Med Case Rep [Internet]. 2010;4(1):191. Available from: https://doi.org/10.1186/1752-1947-4-191

Ren G, Esposito M, Kang Y. Bone metastasis and the metastatic niche. J Mol Med (Berl). 2015;93(11):1203–12.

Article  PubMed  CAS  Google Scholar 

Khung S, Budzik JF, Amzallag-Bellenger E, Lambilliote A, Soto Ares G, Cotten A, et al. Skeletal involvement in Langerhans cell histiocytosis. Insights Imaging. 2013;4(5):569–79.

Article  PubMed  PubMed Central  Google Scholar 

Mosheimer BA, Oppl B, Zandieh S, Fillitz M, Keil F, Klaushofer K, et al. Bone involvement in Rosai-Dorfman disease (RDD): a case report and systematic literature review. Curr Rheumatol Rep. 2017;19(5):29.

Article  PubMed  PubMed Central  Google Scholar 

Demicco EG, Rosenberg AE, Björnsson J, Rybak LD, Unni KK, Nielsen GP. Primary Rosai-Dorfman disease of bone: a clinicopathologic study of 15 cases. Am J Surg Pathol. 2010;34(9):1324–33.

Article  PubMed  Google Scholar 

Kilciksiz S, Karakoyun-Celik O, Agaoglu FY, Haydaroglu A. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. Sci World J. 2012;2012:895765.

Article  Google Scholar 

Weber DM. Solitary bone and extramedullary plasmacytoma. Hematology. 2005;2005(1):373–6.

Article  Google Scholar 

Durie BGM, Kyle RA, Belch A, Bensinger W, Blade J, Boccadoro M, et al. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J. 2003;4(6):379–98.

Article  PubMed  Google Scholar 

Dimopoulos M, Terpos E, Comenzo RL, Tosi P, Beksac M, Sezer O, et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia. 2009;23(9):1545–56.

Article  PubMed  CAS  Google Scholar 

Shi XF, Hu SD, Li JM, Luo XF, Long ZB, Zhu Y, et al. Multimodal imaging and clinical characteristics of bone lesions in POEMS syndrome. Int J Clin Exp Med. 2015;8(5):7467–76.

PubMed  PubMed Central  Google Scholar 

Dispenzieri A. POEMS syndrome. Blood Rev. 2007;21(6):285–99.

Article  PubMed  Google Scholar 

Behzadi AH, Raza SI, Carrino JA, Kosmas C, Gholamrezanezhad A, Basques K, et al. Applications of PET/CT and PET/MR imaging in primary bone malignancies. PET Clin. 2018;13(4):623–34.

Article  PubMed  PubMed Central  Google Scholar 

Haroche J, Amoura Z, Dion E, Wechsler B, Costedoat-Chalumeau N, Cacoub P, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Vol. 83, Medicine. 2004. p. 371–92.

Haroche J, Cohen-Aubart F, Rollins BJ, Donadieu J, Charlotte F, Idbaih A, et al. Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol [Internet]. 2017 Feb 1;18(2):e113–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28214412. Accessed 6 Sept 2023

Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood [Internet]. 2013 Feb 28;121(9):1495–500. Available from: https://doi.org/10.1182/blood-2012-07-446286

Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al. Erdheim-Chester disease clinical and radiologic characteristics of 59 cases. Medicine [Internet]. 1996;75(3). Available from: https://journals.lww.com/md-journal/fulltext/1996/05000/erdheim_chester_disease_clinical_and_radiologic.5.aspx. Accessed 6 Sept 2023

Cohen-Aubart F, Emile JF, Carrat F, Helias-Rodzewicz Z, Taly V, Charlotte F, et al. Phenotypes and survival in Erdheim-Chester disease: results from a 165-patient cohort. Am J Hematol [Internet]. 2018 May 1;93(5):E114–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29396850. Accessed 6 Sept 2023